000302849 001__ 302849
000302849 005__ 20250720021448.0
000302849 0247_ $$2doi$$a10.1016/j.radonc.2025.111035
000302849 0247_ $$2pmid$$apmid:40659192
000302849 0247_ $$2ISSN$$a0167-8140
000302849 0247_ $$2ISSN$$a1879-0887
000302849 0247_ $$2altmetric$$aaltmetric:179420665
000302849 037__ $$aDKFZ-2025-01389
000302849 041__ $$aEnglish
000302849 082__ $$a610
000302849 1001_ $$aMeattini, Icro$$b0
000302849 245__ $$aRepositioning Radiation Oncology at the centre of integrated oncology care: A manifesto of the European Society for Radiotherapy and Oncology (ESTRO).
000302849 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2025
000302849 3367_ $$2DRIVER$$aarticle
000302849 3367_ $$2DataCite$$aOutput Types/Journal article
000302849 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1752739867_14023$$xEditorial
000302849 3367_ $$2BibTeX$$aARTICLE
000302849 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000302849 3367_ $$00$$2EndNote$$aJournal Article
000302849 520__ $$aModern oncology increasingly relies on integrated, multimodality care, yet radiation oncology remains undervalued in strategic frameworks despite its central therapeutic role. This ESTRO manifesto calls for a repositioning of radiation oncology as a core discipline in cancer care, scientifically, clinically, and politically. The field now extends beyond beam delivery to encompass systemic therapy integration, personalised strategies based on biology and imaging, and active participation in clinical decision-making and guideline development. Radiation oncology contributes to treatment sequencing, synergistic combinations, and innovation in areas such as radioligand therapy and artificial intelligence. ESTRO's initiatives, including education, research networks, and oncopolicy engagement, underscore the discipline's broad scope and societal value. Strategic partnerships with Pharma and MedTech, alongside a renewed emphasis on equitable access, are essential to sustaining progress. ESTRO invites all stakeholders to recognise radiation oncology as fundamental to the design, delivery, and evolution of modern cancer therapy.
000302849 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000302849 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000302849 650_7 $$2Other$$aHealth equity
000302849 650_7 $$2Other$$aHealth policy
000302849 650_7 $$2Other$$aMultimodal treatment
000302849 650_7 $$2Other$$aOncology
000302849 650_7 $$2Other$$aOncopolicy
000302849 650_7 $$2Other$$aRadiotherapy
000302849 7001_ $$aAznar, Marianne C$$b1
000302849 7001_ $$aBoldrini, Luca$$b2
000302849 7001_ $$aBorgmann, Kerstin$$b3
000302849 7001_ $$aClark, Catharine H$$b4
000302849 7001_ $$aFaivre-Finn, Corinne$$b5
000302849 7001_ $$aForde, Elizabeth$$b6
000302849 7001_ $$avan der Heide, Uulke A$$b7
000302849 7001_ $$aJereczek-Fossa, Barbara Alicja$$b8
000302849 7001_ $$aJornet, Núria$$b9
000302849 7001_ $$aKirby, Anna M$$b10
000302849 7001_ $$aOst, Piet$$b11
000302849 7001_ $$aRatosa, Ivica$$b12
000302849 7001_ $$aTanderup, Kari$$b13
000302849 7001_ $$0P:(DE-He78)91d4b4a1e36e2bec6c08ac43e6820834$$aTroost, Esther$$b14
000302849 7001_ $$aCortese, Alessandro J$$b15
000302849 7001_ $$aGuckenberger, Matthias$$b16
000302849 773__ $$0PERI:(DE-600)1500707-8$$a10.1016/j.radonc.2025.111035$$gVol. 210, p. 111035 -$$p111035$$tRadiotherapy and oncology$$v210$$x0167-8140$$y2025
000302849 909CO $$ooai:inrepo02.dkfz.de:302849$$pVDB
000302849 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)91d4b4a1e36e2bec6c08ac43e6820834$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000302849 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000302849 9141_ $$y2025
000302849 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2025-01-07$$wger
000302849 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-07
000302849 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-07
000302849 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-07
000302849 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-07
000302849 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-07
000302849 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-07
000302849 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-07
000302849 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-07
000302849 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-07
000302849 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bRADIOTHER ONCOL : 2022$$d2025-01-07
000302849 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-07
000302849 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-07
000302849 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bRADIOTHER ONCOL : 2022$$d2025-01-07
000302849 9201_ $$0I:(DE-He78)DD01-20160331$$kDD01$$lDKTK Koordinierungsstelle Dresden$$x0
000302849 980__ $$ajournal
000302849 980__ $$aVDB
000302849 980__ $$aI:(DE-He78)DD01-20160331
000302849 980__ $$aUNRESTRICTED